DRRX
Price:
$1.57
Market Cap:
$48.73M
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-09-28
Stock Exchange
NASDAQ
Ticker
DRRX
According to DURECT Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -2.57. This represents a change of -17.72% compared to the average of -3.12 of the last 4 quarters.
The mean historical PE Ratio of DURECT Corporation over the last ten years is -26.19. The current -2.57 PE Ratio has changed 881.47% with respect to the historical average. Over the past ten years (40 quarters), DRRX's PE Ratio was at its highest in in the December 2020 quarter at 24.13. The PE Ratio was at its lowest in in the September 2019 quarter at -44.39.
Average
-26.19
Median
-5.50
Minimum
-163.71
Maximum
-0.56
Discovering the peaks and valleys of DURECT Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 888.82%
Maximum Annual PE Ratio = -0.56
Minimum Annual Increase = -96.43%
Minimum Annual PE Ratio = -163.71
Year | PE Ratio | Change |
---|---|---|
2023 | -0.56 | -74.68% |
2022 | -2.21 | -62.10% |
2021 | -5.84 | -96.43% |
2020 | -163.71 | 451.41% |
2019 | -29.69 | 888.82% |
2018 | -3.00 | -91.70% |
2017 | -36.17 | 601.82% |
2016 | -5.15 | -55.41% |
2015 | -11.56 | 192.60% |
2014 | -3.95 | -52.05% |
The current PE Ratio of DURECT Corporation (DRRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.87
5-year avg
-40.40
10-year avg
-26.19
DURECT Corporation’s PE Ratio is less than Shuttle Pharmaceuticals Holdings, Inc. (-0.48), less than Mallinckrodt plc (-0.00), greater than Organogenesis Holdings Inc. (-43.06), less than Lucy Scientific Discovery Inc. (-0.72), greater than Alimera Sciences, Inc. (-20.57), greater than Alpha Teknova, Inc. (-5.47), less than Agile Therapeutics, Inc. (-0.65), greater than Sonoma Pharmaceuticals, Inc. (-12.25), less than Eagle Pharmaceuticals, Inc. (5.10), less than Lifecore Biomedical, Inc. (12.14), less than RedHill Biopharma Ltd. (0.72), less than Taro Pharmaceutical Industries Ltd. (29.99), less than Collegium Pharmaceutical, Inc. (12.07), less than Neurocrine Biosciences, Inc. (35.71), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Ironwood Pharmaceuticals, Inc. (77.85), less than Alkermes plc (15.66), greater than Avadel Pharmaceuticals plc (-13.12), greater than Aquestive Therapeutics, Inc. (-14.78), less than Evoke Pharma, Inc. (-0.81), less than Adamis Pharmaceuticals Corporation (-0.47), greater than Guardion Health Sciences, Inc. (-2.89), less than AcelRx Pharmaceuticals, Inc. (-1.83),
Company | PE Ratio | Market cap |
---|---|---|
-0.48 | $3.42M | |
-0.00 | $4.52M | |
-43.06 | $327.46M | |
-0.72 | $906.91K | |
-20.57 | $302.38M | |
-5.47 | $244.66M | |
-0.65 | $10.43M | |
-12.25 | $3.36M | |
5.10 | $55.19M | |
12.14 | $147.38M | |
0.72 | $11.96M | |
29.99 | $1.62B | |
12.07 | $1.20B | |
35.71 | $12.13B | |
-11.74 | $2.21B | |
77.85 | $720.42M | |
15.66 | $4.42B | |
-13.12 | $1.39B | |
-14.78 | $380.63M | |
-0.81 | $3.17M | |
-0.47 | $7.25M | |
-2.89 | $17.02M | |
-1.83 | $14.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DURECT Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DURECT Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is DURECT Corporation's PE Ratio?
How is the PE Ratio calculated for DURECT Corporation (DRRX)?
What is the highest PE Ratio for DURECT Corporation (DRRX)?
What is the 3-year average PE Ratio for DURECT Corporation (DRRX)?
What is the 5-year average PE Ratio for DURECT Corporation (DRRX)?
How does the current PE Ratio for DURECT Corporation (DRRX) compare to its historical average?